Low-grade B-cell Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Low-grade B-cell Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma [Phase 2]
Phase 2 trial evaluating SyB L-0501 in combination with rituximab for untreated low-grade B-cell non-Hodgkin lymphoma and mantle cell lympho…
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab [Phase 2]
This is a Phase 2 trial evaluating the combination of ofatumumab and bortezomib in patients with low-grade B-cell non-Hodgkin lymphoma that …
-
CLINICAL_TRIALS trial_result · 2012-04-10Clinical Trial Update: Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 pivotal study results for iodine-131 tositumomab in chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin ly…